pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,948 catalysts · 5,063 phase readout · 2,317 8k filing · 316 pdufa · 273 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 21 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,317
  • pdufa316
  • earnings273
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07442149: An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005ALUMIS INC.

    Sponsor: Alumis Inc. Phase: PHASE1. Conditions: Healthy Volunteer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07418138: Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

    Sponsor: Hu Liangshuo. Phase: . Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC), Tyrosine Kinase Inhibitor, Survival Rate

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07362238: Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Immune Thrombocytopenia, Treatment

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04221438: Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node InvolvementArray BioPharma Inc

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Recurrent Cutaneous Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04461158: CCCR Lupus Patient Navigator Program

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Systemic Lupus Erythematosus (SLE)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07307248: To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

    Sponsor: Asian Institute of Gastroenterology, India. Phase: NA. Conditions: Walled Off Necrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06877026: FibroScan-Reproducibility and Repeatability Study

    Sponsor: Echosens. Phase: NA. Conditions: Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07418385: Voluntary HIV Screening in the General Population in France

    Sponsor: Université de Reims Champagne-Ardenne. Phase: . Conditions: Human Immunodeficiency Virus (HIV)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03078543: Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee SystemSMITH & NEPHEW PLC

    Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthroplasty, Replacement, Knee

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07480343: 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

    Sponsor: Iantrek, Inc.. Phase: . Conditions: Open-angle Glaucoma (OAG)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07550543: PEMF Therapy in Shoulder Tendinopathy

    Sponsor: Balnear and Rehabilitation Sanatorium Techirghiol. Phase: NA. Conditions: Shoulder Tendinopathy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07298408: Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot StudyJazz Pharmaceuticals plc

    Sponsor: Florida A&M University. Phase: PHASE1. Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07422025: Prognostic Value of Preoperative Frailty Assessment in Geriatric Lower Limb Orthopedic Surgery

    Sponsor: Benha University. Phase: . Conditions: Lower Limb Fracture

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07414576: AI-driven Total Parenteral Nutrition Platform

    Sponsor: Takeoff41, Inc.. Phase: NA. Conditions: Intestinal Failure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05003817: Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular UnloadingGuy's and St Thomas' NHS Foundation Trust

    Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: PHASE3. Conditions: Ischemic Heart Disease, Coronary Artery Disease

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07450040: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell LymphomaContinuity Biosciences LLC

    Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: ORR, OS, PFS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02280889: Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

    Sponsor: University Children's Hospital, Zurich. Phase: . Conditions: Quality of Life, Stigmatization

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07463768: Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.Bristol-Myers Squibb Co

    Sponsor: French Innovative Leukemia Organisation. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

    Sponsor: Medtronic Cardiovascular. Phase: . Conditions: Aortic Stenosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05316571: Sitting Interruption and Whole-body Cardiovascular Health

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Sedentary Behavior, Sedentary Time

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05537064: Centralized Prescribing for StatinsUniversity of Pennsylvania

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Hyperlipidemias

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07524764: Female Reproductive Health in Canadian Armed Forces

    Sponsor: Université de Sherbrooke. Phase: . Conditions: Pregnancy, Pelvic Floor Dysfunction, Military Personnel, Contraception, Infertility, Women's Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04602598: Zanubrutinib in Patients With IgG4-Related DiseaseBeOne Medicines Ltd.

    Sponsor: Matthew C. Baker. Phase: PHASE2. Conditions: IgG4 Related Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05470998: L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

    Sponsor: Tanta University. Phase: PHASE3. Conditions: Sickle Cell Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06778863: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationC4 Therapeutics, Inc.

    Sponsor: Clasp Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumor, Unresectable Solid Tumor, Metastatic Solid Tumor, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma, Prostate Cancer, Bladder Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05289687: Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLJOHNSON & JOHNSON

    Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07416487: Comparison of Outcome of Foley Catheter Versus Misoprostol for Induction of LaborAFYX Therapeutics A/S

    Sponsor: Muhammad Aamir Latif. Phase: NA. Conditions: Labor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05064293: Assisted Identification and Navigation of Early Mental Health Symptoms in Children

    Sponsor: Kaiser Permanente. Phase: NA. Conditions: Adolescent Behavior, Mental Health Issue

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06896916: Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaAbbVie Inc.

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06472284: TetraGraph in Rocuronium Infusions

    Sponsor: Joseph D. Tobias. Phase: NA. Conditions: Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04849884: To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System.SMITH & NEPHEW PLC

    Sponsor: Smith & Nephew, Inc.. Phase: NA. Conditions: Arthroplasty, Replacement, Knee

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07544784: AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)

    Sponsor: Fudan University. Phase: PHASE2. Conditions: Colorectal Cancer Liver Metastases (CRLM)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07197684: Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer SurgeryNRX Pharmaceuticals, Inc.

    Sponsor: Aga Khan University. Phase: NA. Conditions: Breast Cancer, Pain, Chronic, Post Surgical Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05773833: Indigenous Supported Agriculture "Go Healthy"Metallomix Inc

    Sponsor: Oklahoma State University Center for Health Sciences. Phase: NA. Conditions: Diet, Healthy, Blood Pressure, Overweight or Obesity, Food Insecurity, Health Status

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02828852: Study of the Platelet Function During the Last Month of Pregnancy

    Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Pregnancy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512947: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE1. Conditions: System Lupus Erythematosus(SLE)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07501949: H-Wave® Device Stimulation for Post-operative Rotator Cuff Repair Surgery

    Sponsor: Electronic Waveform Lab. Phase: NA. Conditions: Rotator Cuff Tear Surgical Repair

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03252249: Duration of Dual Anti-Platelet Therapy (DUAL-ACS)

    Sponsor: University of Edinburgh. Phase: PHASE4. Conditions: Acute Coronary Syndrome, Coronary Artery Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04533958: Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

    Sponsor: Saint-Gregoire Private Hospital Center. Phase: NA. Conditions: Metastatic Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07378358: Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study

    Sponsor: First Affiliated Hospital of Fujian Medical University. Phase: . Conditions: Urologic Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07320378: Clinical Study on the Safety and Efficacy of Tendon Stem Progenitor Cells Therapy for Rotator Cuff Tears

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: EARLY_PHASE1. Conditions: Rotator Cuff Tendinopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07321626: Romiplostim N01 for Platelet Recovery After Haploidentical HSCTAMGEN INC

    Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Delayed Platelet Engraftment, HSCT

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07257185: MHB018A Treatment in Patients With Chronic Thyroid Eye DiseaseMinghui Pharmaceutical (Shanghai) Co Ltd

    Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd. Phase: PHASE3. Conditions: Thyroid Eye Disease (TED)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07154043: Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

    Sponsor: Pamukkale University. Phase: NA. Conditions: Breast Cancer-Related Lymphedema, BCRL

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05189925: NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Chronic Granulomatous Disease, Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05608525: Upper Limb tDCS in Chronic Stroke Patients (NOURISH)

    Sponsor: National University Hospital, Singapore. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06860425: Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

    Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Mobile Applications, Cancer Patients

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05344443: Lemborexant Shift Work Treatment StudyUniversity of California San Francisco

    Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: Shift-Work Related Sleep Disturbance

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04238715: A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene FusionEisai Co Ltd

    Sponsor: Eisai Co., Ltd.. Phase: PHASE2. Conditions: Cholangiocarcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07500571: The Correlation Between Neck Posture and Scapular Posture & the Effect Stabilization Exercises for the Scapula

    Sponsor: Hallym University Dongtan Sacred Heart Hospital. Phase: NA. Conditions: Scapular Pain

    full page →ctgov ↗
    ← prev
    page 59 of 159
    next →
    $ALMS27.03-0.18%
    $JNJ266.73+0.29%
    $CCCC
    $ONC330.46+1.40%
    $JAZZ256.92+0.58%
    $SNN30.25+5.29%
    $ABBV263.20+2.45%
    $SNN30.25+5.29%
    $AMGN393.10+4.48%
    $NRXP